Press ReleaseCardiawave announces positive 6-month data from its Valvosoft Pivotal Study, presented at TCT Conference ! Oct 29, 2024 READ MORE
EventsPr Hélène Eltchaninoff presenting Cardiawave’s latest clinical studies at TCT 2024 in Washington ! Oct 7, 2024 READ MORE
EventsJournée Mondiale du Coeur: Pr Hélène Eltchaninoff soutient les nouvelles solutions thérapeutiques telles que Valvosoft® pour la prise charge de la sténose aortique Sep 30, 2024 READ MORE
EventsClara Magnier, PhD student, presenting at the ISTU 2024 conference in Taipei (Taiwan) ! Sep 19, 2024 READ MORE
EventsCardiawave’s latest clinical studies results presented by Dr Marleen Van Wely and Prof. Emmanuel Messas at ESC Congress 2024 ! Aug 29, 2024 READ MORE
EventsGroundbreaking presentation at the Cardio World Congress 2024 by Dr Danijela Trifunovic ! Jul 3, 2024 READ MORE
Press ReleaseCardiawave appoints Olivier Pierron as its Chief Executive Officer Apr 16, 2024 READ MORE
Press ReleaseCardiawave annonce la nomination d’Olivier Pierron en tant que Directeur Général Apr 16, 2024 READ MORE
Press ReleaseCardiawave is presenting the 30-day follow-up results from its “Valvosoft® Pivotal Study” on the treatment of severe symptomatic aortic valve stenosis at the 73rd Annual Conference of the ACC – April 6–8, 2024, Atlanta (GA) Apr 5, 2024 READ MORE
